Local Doctors Develop New Asthma Test
(KDKA) PITTSBURGH Doctors at Children's Hospital in Pittsburgh have developed a new way to find out if children are suffering from asthma.Often times when dealing with the youngest patients, doctors cannot label it asthma because patients are too young for a definitive diagnostic test called spirometry.
You have to be six or older, and be able to breathe in deeply and blow out all the air.
"That maneuver is very difficult and requires a lot of effort," said Dr. Jonathan Finder. "It's very hard to get children to understand the concept."
by Gloria Payne, DNJ
OTTAWA, ONTARIO--(CCNMatthews - Dec. 7, 2006) - The Canadian Food Inspection Agency (CFIA) is warning people with allergies to almond, peanut, or hazelnut proteins not to consume the Schär brand Wafers and Biscotti products described below. The affected products may contain almonds, peanuts, and hazelnuts, which are not declared on the label.
LACKLAND AIR FORCE BASE, Texas (AFPN) -- A 59th Medical Wing allergy team won the 15th Annual American College of Allergy, Asthma and Immunology Fellows-in-Training Bowl held Nov. 6 in Philadelphia. 
Nearly half of the U.S. population lives in areas with unhealthy ozone levels, according to a 2006 report. For people with respiratory and lung diseases, especially the estimated 20 million Americans with asthma, "bad air" days pose an exceptionally high risk. The health risks associated with high levels of ozone aren't limited to summer months, and people can feel the effects of smog all year long. 
AUSTRALIA - Asthma is the most-common medical condition amongst Canberra school students and a leading cause of absenteeism affecting one in six students.
About 2.2 million school-aged children, or 4 percent of U.S. students, have food allergies, and 3.3 million Americans of all ages are allergic to peanuts or tree nuts, according to the Food Allergy and Anaphylaxis Network. 
For children who have persistent asthma of any degree, inhaled corticosteroid (ICS) treatment is recommended. However, there is ongoing debate with regard to the potential adverse systemic effects and safety of long-term use of these agents, particularly in children. This concern mainly stems from the findings from studies assessing the effects of ICS on lower-leg growth rate or the hypothalamic-pituitary-adrenal axis.[1] The current consensus is that ICS are highly effective and, because their benefits clearly exceed potential risks, can be used safely in children who have persistent asthma.[2,3]
Subscribe to feed